---
action_items:
- id: c5c0ec59e026
  severity: science
  text: Report confidence intervals or standard deviations for all success rates (Tables
    1-10). Single-point estimates prevent assessing statistical significance of claimed
    gains (e.g., +2.9pp RL gain).
- id: 88ced6e88714
  severity: science
  text: Clarify the number of independent seeds or trials used for aggregate success
    rates. The text mentions '128 parallel envs' but does not specify if benchmark
    scores are averages over multiple seeds, which is critical for variance estimation.
- id: 214fa17c6cca
  severity: science
  text: Address the multiple-comparisons problem in ablation studies (Tables 11-14).
    With many configurations tested, lack of correction (e.g., Bonferroni) risks inflating
    Type I error rates for claimed 'marginal gains'.
artifact_hash: 4317c2f95ff2f77ca9da4f22e56217afc73d1946ecdbafc6b1dfd103e809ccd5
artifact_path: projects/PROJ-645-qwen-vla-unifying-vision-language-action/paper/metadata.json
backend: dartmouth
feedback: ''
github_authenticated: false
model_name: qwen.qwen3.5-122b
prompt_version: 1.1.0
reviewed_at: '2026-07-03T18:14:01.487256Z'
reviewer_kind: llm
reviewer_name: paper_reviewer_statistical_analysis
score: 0.0
verdict: minor_revision
---

The statistical reporting in the manuscript is insufficient to support the robustness of the claimed improvements. While the paper presents extensive numerical results across multiple benchmarks (LIBERO, Simpler, RoboTwin, DOMINO, VLN-CE), it consistently reports single-point success rates (e.g., 97.9%, 73.7%) without accompanying measures of variance such as standard deviations, confidence intervals, or standard errors. This is a critical omission in empirical robotics and machine learning research, where performance can vary significantly based on random seeds, environment initialization, or stochastic policy execution.

Specifically, in Tables 1 through 10, the authors claim statistically significant improvements (e.g., "outperforming $\pi_{0.5}$ by 35.4 percentage points" in Table 3, or "+2.9pp" gain from RL in Table 12). Without reporting the variance across independent trials or seeds, it is impossible to determine if these differences are statistically significant or merely artifacts of random variation. The text mentions using "128 parallel envs" for RL rollouts (Section 5.2), but this refers to parallelization within a single run, not the number of independent experimental seeds required to estimate population variance.

Furthermore, the ablation studies (Tables 11-14) involve testing multiple configurations (e.g., different projection heads, state conditioning strategies, T2A hyperparameters). The manuscript does not address the multiple-comparisons problem. When testing many hypotheses, the probability of finding a "significant" result by chance increases. The authors should either apply a correction method (e.g., Bonferroni, False Discovery Rate) or explicitly frame these as exploratory analyses where the lack of correction is acknowledged.

Finally, the sample sizes for the real-world ALOHA experiments (Table 2) are not explicitly stated. How many trials were conducted per task category? Without this information, the reliability of the 83.6% average success rate cannot be assessed. The authors must provide the number of seeds/trials, report variance metrics (mean $\pm$ std), and clarify the statistical testing methodology used to validate their claims.
